CM Hospitalar S/A (BVMF:VVEO3)
1.330
0.00 (0.00%)
Last updated: Mar 13, 2026, 4:23 PM GMT-3
CM Hospitalar S/A Cash Flow Statement
Financials in millions BRL. Fiscal year is January - December.
Millions BRL. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 18.24 | -1,415 | 359.92 | 259.73 | 395.16 |
Depreciation & Amortization | 330.37 | 266.85 | 227.44 | 176.36 | 98.19 |
Other Amortization | - | 44.27 | 33.18 | - | - |
Loss (Gain) From Sale of Assets | - | 222.66 | -9.52 | 6.35 | 2.28 |
Asset Writedown & Restructuring Costs | 8.66 | - | - | - | - |
Loss (Gain) From Sale of Investments | - | 97.26 | - | - | - |
Loss (Gain) on Equity Investments | 1 | 11.86 | 1.68 | 3.53 | 3 |
Stock-Based Compensation | 3.17 | 4.42 | 6.94 | 4.51 | - |
Provision & Write-off of Bad Debts | 26.78 | 109.94 | -8.46 | 5.97 | 1.34 |
Other Operating Activities | -185.49 | 888.2 | -208.34 | 93.62 | -42 |
Change in Accounts Receivable | 56.75 | 216.76 | -404.93 | -387.02 | -67.75 |
Change in Inventory | 45.16 | -138.82 | -684.34 | -53.06 | -162.7 |
Change in Accounts Payable | 42.09 | -397.78 | -55.49 | 441.66 | 185.57 |
Change in Income Taxes | -89.41 | 109 | -193.82 | -14.27 | -132.54 |
Change in Other Net Operating Assets | 14.08 | 15.02 | 40.11 | -4.63 | 39.58 |
Operating Cash Flow | 276.58 | 34.15 | -895.63 | 532.75 | 320.12 |
Operating Cash Flow Growth | 709.90% | - | - | 66.42% | 72.47% |
Capital Expenditures | -45.49 | -81.62 | -168.1 | -152.24 | -77.95 |
Sale (Purchase) of Intangibles | -105.82 | -103.67 | -134.18 | -107.08 | -48.24 |
Investment in Securities | 487.37 | -57.7 | 370.82 | -1,318 | -1,184 |
Other Investing Activities | - | -29.8 | -68.15 | -32.31 | -105.58 |
Investing Cash Flow | 336.05 | -272.79 | 0.39 | -1,609 | -1,416 |
Long-Term Debt Issued | 63.87 | 1,450 | 232.35 | 1,389 | 1,589 |
Long-Term Debt Repaid | -519.89 | -983.02 | -384.54 | -296.55 | -685.85 |
Net Debt Issued (Repaid) | -456.02 | 467.4 | -152.18 | 1,092 | 903.26 |
Issuance of Common Stock | - | - | 778.35 | - | 652.87 |
Repurchase of Common Stock | - | -18.72 | - | -40.45 | -25.36 |
Common Dividends Paid | - | -43.48 | - | -112.99 | - |
Other Financing Activities | -126.63 | -95.59 | -300.79 | -184.3 | -7.66 |
Financing Cash Flow | -582.65 | 309.61 | 325.38 | 754.34 | 1,523 |
Net Cash Flow | 29.98 | 70.96 | -569.86 | -322.29 | 427.51 |
Free Cash Flow | 231.09 | -47.47 | -1,064 | 380.51 | 242.16 |
Free Cash Flow Growth | - | - | - | 57.13% | 77.73% |
Free Cash Flow Margin | 2.00% | -0.41% | -9.60% | 4.35% | 3.89% |
Free Cash Flow Per Share | 0.73 | -0.15 | -3.54 | 1.34 | 0.93 |
Cash Interest Paid | 512.64 | 412.76 | 450.52 | 245.01 | 78.88 |
Cash Income Tax Paid | 31.33 | 23.97 | 73.51 | 58.48 | 28.66 |
Levered Free Cash Flow | 331.55 | -85.56 | -1,585 | 68.85 | 35.39 |
Unlevered Free Cash Flow | 700.87 | 220.34 | -1,292 | 68.85 | 277.11 |
Change in Working Capital | 68.67 | -195.82 | -1,298 | -17.31 | -137.84 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.